BN43118 | Roche/Genentech | First US Site Activation | Center for Clinical Research | UCI

Jump to Header Jump to Main Content Jump to Footer

For UCI Researchers interested in learning more about CCR resources and support, please contact us.

UCI Researcher Inquiries

»
News and Events
»
BN43118 | Roche/Genentech | First US Site Activation

BN43118 | Roche/Genentech | First US Site Activation

10/20/2022 Genentech, Inc.

UCI is the first site in the US to be open and activated in the US for the BN43118 study led by Dr. Manisha Korb.

News & Events

12/08/2023 UCI HealthUCI Health enrolls patient in first U.S. study of medical device for erectile dysfunction
- Faculty
- Health
- In the News
11/15/2023 UCI HealthSickle cell disease treatment nearing FDA approval
- Faculty
- Health
- In the News
11/01/2023 His GERD is now a distant memory
- Faculty
- Health
- In the News

More News & Events